JPS6236675B2 - - Google Patents
Info
- Publication number
- JPS6236675B2 JPS6236675B2 JP17092779A JP17092779A JPS6236675B2 JP S6236675 B2 JPS6236675 B2 JP S6236675B2 JP 17092779 A JP17092779 A JP 17092779A JP 17092779 A JP17092779 A JP 17092779A JP S6236675 B2 JPS6236675 B2 JP S6236675B2
- Authority
- JP
- Japan
- Prior art keywords
- glutamic acid
- acetic acid
- medium
- acid
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 60
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 28
- 229960002989 glutamic acid Drugs 0.000 claims description 16
- 241000186146 Brevibacterium Species 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 6
- 230000004151 fermentation Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 3
- 229930195729 fatty acid Natural products 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 150000004665 fatty acids Chemical class 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 1
- 238000009630 liquid culture Methods 0.000 claims 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 16
- 239000002609 medium Substances 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229960002685 biotin Drugs 0.000 description 8
- 235000020958 biotin Nutrition 0.000 description 8
- 239000011616 biotin Substances 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000004202 carbamide Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 description 4
- 108020003285 Isocitrate lyase Proteins 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 235000013379 molasses Nutrition 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910001410 inorganic ion Inorganic materials 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- -1 aliphatic alcohols Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Description
この発明は発酵法によるL−グルタミン酸の製
造法に関する。
L−グルタミン酸は、ブレビバクテリウム属、
又はコリネバクテリウム属に属する微生物を使用
して発酵法により製造されている。
本発明者らは、従来知られているブレビバクテ
リウム属のL−グルタミン酸生産菌に酢酸要求性
を付与した変異株を誘導したところ、特に炭素源
として脂肪族アルコール又は脂肪酸と糖質とを併
用する場合において、この変異株が従来知られて
いるL−グルタミン酸生産菌より、高い収率でL
−グルタミン酸を生成蓄積することを知つた。
本発明に使用する変異株はブレビバクテリウム
属に属し、酢酸要求性を有する変異株であり、例
えば以下の菌株が挙げられる。
ブレビバクテリウム・ラクトフエルメンタム
AJ 11515(FERMP 5335)(酢酸要求性株)
ブレビバクテリウム・ラクトフエルメンタム
AJ 11516(FERMP 5336)(酢酸要求性、イソ
エクエン酸リアーゼ低下株)
ブレビバクテリウム・フラバム
AJ 11517(FERMP 5337)(酢酸要求性株)
AJ11515及びAJ11516はATCC13869を、
AJ11517はATCC14067をそれぞれ親株として誘
導された。他に親株としては、ブレビバクテリウ
ム・サツカロリテイカムATCC14066、ブレビバ
クテリウム・デイバリカタムATCC14020等の
ブレビバクテリウム属のL−グルタミン酸生産菌
が使用できる。
上記変異株の変異誘導法としては、紫外線照
射、放射線照射、変異誘導起剤処理等の通常の方
法が用いられ、例えば200μg/mlのN−メチル
−N′−ニトロ−N−ニトロソグアニジンで0℃
で20分間処理する方法等がある。
上記例示の菌株の酢酸添加濃度に対する生育度
を次の第1表に示す。各菌株の生育度は、次のよ
うにして検定した。
グルコース0.5g/dl、尿素0.15g/dl、硫安
0.15g/dl、KH2PO40.3g/dl、K2HPO40.1g/
dl、MgSO4・7H2O0.01g/dl、CaCl2・2H2O0.1
mg/dl、サイアミン塩酸塩10μg/dl、ビオチン
3μg/dl、Na2B4O7・10H2O0.44mg/dl、
FeCl2・6H2O4.85mg/dl、CuSO4・5H2O1.95
mg/dl、(NH4)6MO7O24・4H2O0.185mg/dl、
ZnSO4・7H2O44mg/dl、MnCl2・4H2O0.3mg/dl
および表に示す量の酢酸を含みpH7.0に調節し
た培地に、天然培地(ペプトン1g/dl、酵母エ
キス1g/dl、NaCl0.5g/dl、pH7.0)スラント
で24時間培養した菌を無菌水で懸濁して接種し、
24時間培養して生育値を濁度で測定した。
The present invention relates to a method for producing L-glutamic acid by fermentation. L-glutamic acid is produced by Brevibacterium spp.
Alternatively, it is produced by a fermentation method using microorganisms belonging to the genus Corynebacterium. The present inventors derived a mutant strain of a previously known L-glutamic acid producing bacterium of the genus Brevibacterium that was endowed with acetic acid auxotrophy. In cases where this mutant strain produces L-glutamic acid in a higher yield than the previously known L-glutamic acid producing bacteria,
-I learned that glutamic acid is produced and accumulated. The mutant strains used in the present invention belong to the genus Brevibacterium and have an acetic acid requirement, and include, for example, the following strains. Brevibacterium lactofermentum AJ 11515 (FERMP 5335) (acetic acid auxotrophic strain)
Brevibacterium lactofermentum AJ 11516 (FERMP 5336) (acetic acid auxotrophic, isoecitrate lyase reduced strain) Brevibacterium flavum AJ 11517 (FERMP 5337) (acetic acid auxotrophic strain) AJ11515 and AJ11516 are ATCC13869,
AJ11517 was derived from ATCC14067 as the parent strain, respectively. Other parent strains that can be used include L-glutamic acid-producing bacteria of the genus Brevibacterium, such as Brevibacterium satucaroliticum ATCC 14066 and Brevibacterium deivaricata ATCC 14020. To induce mutations in the above mutant strains, conventional methods such as ultraviolet irradiation, radiation irradiation, and treatment with mutagenic agents are used. For example, 200 μg/ml of N-methyl-N'-nitro-N-nitrosoguanidine ℃
There are methods such as processing for 20 minutes. The growth rates of the above-mentioned exemplified bacterial strains with respect to the concentration of acetic acid added are shown in Table 1 below. The growth rate of each strain was tested as follows. Glucose 0.5g/dl, urea 0.15g/dl, ammonium sulfate
0.15g/dl, KH 2 PO 4 0.3g/dl, K 2 HPO 4 0.1g/
dl, MgSO 4・7H 2 O0.01g/dl, CaCl 2・2H 2 O0.1
mg/dl, thiamine hydrochloride 10 μg/dl, biotin 3 μg/dl, Na 2 B 4 O 7・10H 2 O 0.44 mg/dl,
FeCl 2・6H 2 O4.85mg/dl, CuSO 4・5H 2 O1.95
mg/dl, (NH 4 ) 6 MO 7 O 24・4H 2 O0.185 mg/dl,
ZnSO 4・7H 2 O44mg/dl, MnCl 2・4H 2 O0.3mg/dl
Bacteria were cultured for 24 hours in a natural medium (peptone 1 g/dl, yeast extract 1 g/dl, NaCl 0.5 g/dl, pH 7.0) on a slant in a medium containing the amount of acetic acid shown in the table and adjusted to pH 7.0. Suspend and inoculate with sterile water,
After culturing for 24 hours, the growth value was measured by turbidity.
【表】
又、上記例示のイソクエン酸リアーゼ(以下
ICLと略記する)低下株のICL活性を第2表に示
す。
ICL活性は次の様にして検定した。[Table] Also, isocitrate lyase exemplified above (hereinafter
Table 2 shows the ICL activity of the reduced strains (abbreviated as ICL). ICL activity was assayed as follows.
【表】
グルコース2.5g/dl、酢酸アンモニウム0.8
g/dl、KH2PO40.1g/dl、MgSO4・7H2O0.1
g/dl、FeSO4・7H2O0.1g/dl、FeSO4・
7H2O1mg/dl、MnSO4・4H2O1mg/dl、尿素0.4
g/dl、ビオチン0.3μg/dl、サイアミン・塩
酢酸20μg/dl、および大豆分解濃縮液(T−N
として)48mg/dl(pH7.0)を含有する培地を調
整し、その20mlずつを500ml容振盪フラスコに入
れ、115℃で10分間加熱殺菌した。この培地に試
験菌株を接種し、往復振盪培養機により、31.5℃
で、対数増殖初期(10〜16時間)まで培養した。
培養液より菌体を分離し、洗浄後超音波粉砕し、
セフアデラクスG−10で処理したものを酵素標品
として用いた。
酵素活性の測定は、椎尾らの方法に準じて行な
つた。
(ジャーナル・オブ・バイオケミストリー 49
巻262頁 1961年)
これらの変異株を培養する培地は、酢酸要求性
を満足せしめるべき物質を含有するほかは、炭素
源、窒素源、無機イオン、更に必要に応じ有機微
量栄養素を含有する通常の培地である。
酢酸要求性を満足せしめるべき栄養源としては
酢酸、プロピオン酸等の低級脂肪酸、パルミチン
酸、ステアリン酸等の高級脂肪酸、エタノール、
プロパノール等の脂肪族アルコールがある。
炭素源として、糖質のほかに上記酢酸要求性を
満足せしめるべき物質も使用できる。特に糖質と
上記酢酸要求性を満足せしめるべき物質が炭素源
として併用された場合により好ましい結果が得ら
れる。併用する場合の糖質と酢酸要求性を満足せ
しめるべき物質の使用量は、炭素源の種類によつ
て異なるが、通常重量にて前者が3〜2に対し、
後者が2〜1の割合が望ましい。糖質としては、
グルコース、フラクトース、シユクロース等の単
糖又はオリゴ糖及びこれらを含有する澱粉、セル
ロース等の加水分解物、果汁、甘蔗廃糖蜜、甜菜
廃糖蜜、大豆ホエイ等が使用できる。
窒素源としては例えば通常のL−グルタミン酸
発酵に用いられるアンモニウム塩、アンモニア水
アンモニアガス、尿素等が用いられ、その他必要
に応じて、リン酸塩、マグネシウム塩等の無機イ
オンが適宜培地に添加される。また必要に応じて
サイアミン、ビオチン等の微量栄養素が適宜使用
される。さらに、ビオチンが過剰に存在する培地
には、ポリオキシエチレンソルビタンモノパルミ
テート、ペニシリン等のビオチン作用抑制物質が
常法により培地に添加される。培養は好気的条件
下で行うのがよく、培養温度は24〜37℃、培養中
pHは6〜9に制御するのがよく、pHの調整には無
機あるいは有機の酸性あるいはアルカリ性物質、
さらには尿素、炭酸カルシウム、アンモニアガス
等を使用することができる。発酵液からのL−グ
ルタミン酸の採取はイオン交換樹脂法、その他の
公知の方法を適宜組合せることにより行われる。
実施例 1
グルコーズ2.3g/dl、酢酸アンモニウム1
g/dl、酢酸ナトリウム1g/dl、KH2PO40.1
g/dl、MgSO4・7H2O0.1g/dl、サイアミン.
塩酸塩20μg/dl、尿素0.6g/dl、FeSO4・
7H2O1mg/dl、MnSO4・4H2O1mg/dl、大豆分解
濃縮液(T−Nとして)36mg/dlおよびビオチン
2μg/(pH7.0)を含有する培地を調製し、
その20mlずつを500ml容振盪フラスコに入れ115℃
で10分加熱殺菌した。
この培地にそれぞれ下記の表の菌を接種し往復
振盪培養機により31.5℃で培養を行つた。
なお、培養中は培養液をpH6.5〜8.0に保つた
め、45g/dl尿素又は2NH2SO4を用いて調整し
た。
36時間で培養を終了し、培養液中に蓄積したL
−グルタミン酸の対基質収率を求めた。その結果
を、次の第3表に示す。[Table] Glucose 2.5g/dl, ammonium acetate 0.8
g/dl, KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O0.1
g/dl, FeSO 4・7H 2 O0.1g/dl, FeSO 4・
7H 2 O1 mg/dl, MnSO 4・4H 2 O1 mg/dl, urea 0.4
g/dl, biotin 0.3 μg/dl, thiamine/hydroacetic acid 20 μg/dl, and soybean decomposition concentrate (T-N
A medium containing 48 mg/dl (pH 7.0) was prepared, and 20 ml of each was placed in a 500 ml shake flask and sterilized by heating at 115°C for 10 minutes. This medium was inoculated with the test bacterial strain and incubated at 31.5°C using a reciprocating shaking incubator.
The cells were cultured until early logarithmic growth (10 to 16 hours).
Isolate the bacterial cells from the culture solution, wash them, and crush them with ultrasonic waves.
The enzyme treated with Cephaderax G-10 was used as an enzyme preparation. Enzyme activity was measured according to the method of Shiio et al. (Journal of Biochemistry 49
(Vol. 262, 1961) The medium for culturing these mutant strains is a normal medium that contains substances that satisfy the acetic acid requirement, as well as carbon sources, nitrogen sources, inorganic ions, and, if necessary, organic micronutrients. It is a medium for Nutrient sources that should satisfy the requirement for acetic acid include lower fatty acids such as acetic acid and propionic acid, higher fatty acids such as palmitic acid and stearic acid, ethanol,
There are aliphatic alcohols such as propanol. As a carbon source, in addition to carbohydrates, substances that satisfy the above-mentioned requirement for acetic acid can also be used. In particular, more favorable results can be obtained when a carbohydrate and a substance that satisfies the above-mentioned requirement for acetic acid are used together as carbon sources. When used in combination, the amount of the substance required to satisfy carbohydrate and acetic acid requirements varies depending on the type of carbon source, but the former is usually 3 to 2 by weight;
A ratio of 2 to 1 for the latter is desirable. As carbohydrates,
Monosaccharides or oligosaccharides such as glucose, fructose, and sucrose, and starch containing these, hydrolysates of cellulose and the like, fruit juice, cane molasses, sugar beet molasses, soybean whey, and the like can be used. As nitrogen sources, for example, ammonium salts, ammonia water, ammonia gas, urea, etc. used in normal L-glutamic acid fermentation are used, and inorganic ions such as phosphates and magnesium salts are added to the medium as necessary. Ru. Additionally, micronutrients such as thiamine and biotin are used as appropriate. Furthermore, a biotin action inhibitor such as polyoxyethylene sorbitan monopalmitate or penicillin is added to the medium in which biotin is present in excess by a conventional method. Cultivation is best carried out under aerobic conditions, with a culture temperature of 24-37℃, during cultivation
It is best to control the pH between 6 and 9, and use inorganic or organic acidic or alkaline substances to adjust the pH.
Furthermore, urea, calcium carbonate, ammonia gas, etc. can be used. Collection of L-glutamic acid from the fermentation liquor is carried out by appropriately combining the ion exchange resin method and other known methods. Example 1 Glucose 2.3g/dl, ammonium acetate 1
g/dl, sodium acetate 1g/dl, KH 2 PO 4 0.1
g/dl, MgSO 4 7H 2 O0.1g/dl, thiamine.
Hydrochloride 20μg/dl, urea 0.6g/dl, FeSO 4 .
Prepare a medium containing 7H 2 O 1 mg/dl, MnSO 4 4H 2 O 1 mg/dl, soybean decomposition concentrate (as T-N) 36 mg/dl and biotin 2 μg/(pH 7.0),
Pour 20ml of each into a 500ml shaking flask and heat to 115°C.
Sterilized by heating for 10 minutes. Each of the bacteria shown in the table below was inoculated into this medium and cultured at 31.5°C using a reciprocating shaking incubator. During cultivation, the pH of the culture solution was maintained at 6.5 to 8.0 using 45 g/dl urea or 2NH 2 SO 4 . The culture was completed after 36 hours, and the L accumulated in the culture solution
- The yield of glutamic acid versus substrate was determined. The results are shown in Table 3 below.
【表】
実施例 2
ブレビバクテリウム・ラクトフエルメンタム
ATCC13869及びAJ11516を、甘蔗廃糖蜜(全糖
として)5.6g/dl、酢酸1.4g/dl、KH2PO40.2
g/dl、MgSO4・7H2O0.1g/dl、硫酸アンモニ
ウム0.05g/dl、MnSO4・4H2O1mg/dl、
FeSO4・7H2O1mg/dl、ビオチン3μg/、大
豆加水分解濃縮液を(全窒素として)36mg/dl、
及びサイアミン塩酸塩200μg/lを含有する培
地300mlを、1.5容ジャーフアーメンターに張込
み120℃で15分間滅菌した。
この培地に前培養した菌を接種し、31.5℃でpH
を7.8に保ちつつ振とう培養した。
培養開始後、培養液の26倍希釈液の562nmに
おける吸光度が、0.3に到達した時にポリオキシ
エチレンソルビタンモノパルテイトを添加した。
又、培養液中の残存酢酸が0.1g/dl以下にな
つた時点で、あらかじめ調整したフイード液(甘
蔗廃糖蜜、17g/dl、酢酸アンモニウム(酢酸分
として)15g/dl、酢酸15g/dl、酢酸ナトリウ
ム(酢酸分として)13g/dlを含む)を残存酢酸
濃度が常に0.1〜0.5g/dlの範囲にとどまるよう
に、フイード液を連続的に補給した。
以上の結果培養48時間後第4表に示す量のL−
グルタミン酸が培養液中に生成蓄積した。[Table] Example 2 Brevibacterium lactofermentum
ATCC13869 and AJ11516, cane molasses (as total sugar) 5.6g/dl, acetic acid 1.4g/dl, KH 2 PO 4 0.2
g/dl, MgSO 4・7H 2 O0.1g/dl, ammonium sulfate 0.05g/dl, MnSO 4・4H 2 O1mg/dl,
FeSO 4 7H 2 O 1 mg/dl, biotin 3 μg/dl, soybean hydrolysis concentrate (as total nitrogen) 36 mg/dl,
300 ml of a medium containing 200 μg/l of thiamine hydrochloride was poured into a 1.5 volume jar fermenter and sterilized at 120° C. for 15 minutes. This medium was inoculated with the pre-cultured bacteria, and the pH was adjusted to 31.5°C.
Culture was carried out with shaking while maintaining the temperature of 7.8. After the start of culture, polyoxyethylene sorbitan monopartate was added when the absorbance at 562 nm of the 26-fold dilution of the culture solution reached 0.3. Also, when the residual acetic acid in the culture solution is 0.1 g/dl or less, add the previously prepared feed solution (cane molasses, 17 g/dl, ammonium acetate (as acetic acid content) 15 g/dl, acetic acid 15 g/dl, The feed liquid was continuously replenished with sodium acetate (containing 13 g/dl as acetic acid content) so that the residual acetic acid concentration always remained in the range of 0.1 to 0.5 g/dl. After 48 hours of culture, the amount of L- shown in Table 4 was as follows.
Glutamic acid was produced and accumulated in the culture medium.
【表】
実施例 3
グルコーズ1g/dl、エタノール0.5g/dl、
KH2PO40.1g/dl、MgSO4・7H2O0.1g/dl、
MnSO4・4H2O1mg/dl、FeSO4・7H2O1mg/dl、
ビオチン3μg/dl、硫酸アンモニウム1.0g/
dl、大豆加水分解濃縮液(全窒素として)96mg/
dl、サイアミン・塩酸塩200μg/を含有する
培地を調製し、その30mlを、500ml容振とうフラ
スコに分注し、115℃で10分間加熱殺菌した。ブ
レビバクテリウム・ラクトフエルメンタム
ATCC13869又はAJ11516を、接種し、往復振盪
培養機により31.5℃で培養を行なつた。
初発培地中のエタノールが、消費された時点か
らフイード液(グルコーズ30g/dl、エタノール
15g/dl、硫安15g/dl、を含有する)の1.4g/
dl量を2回添加し、36時間で培養を終了した。
第5表に、発酵液中に蓄積したL−グルタミン
酸の使用炭素源に対する収率を示す。[Table] Example 3 Glucose 1g/dl, Ethanol 0.5g/dl,
KH 2 PO 4 0.1g/dl, MgSO 4・7H 2 O0.1g/dl,
MnSO 4・4H 2 O1 mg/dl, FeSO 4・7H 2 O1 mg/dl,
Biotin 3μg/dl, ammonium sulfate 1.0g/
dl, soybean hydrolysis concentrate (as total nitrogen) 96mg/
A medium containing 200 μg/dl of thiamine hydrochloride was prepared, and 30 ml of the medium was dispensed into a 500 ml shake flask and sterilized by heating at 115° C. for 10 minutes. Brevibacterium lactofermentum
ATCC13869 or AJ11516 was inoculated and cultured at 31.5°C using a reciprocating shaking incubator. Once the ethanol in the initial culture medium has been consumed, the feed liquid (glucose 30g/dl, ethanol
15g/dl, ammonium sulfate 15g/dl)
dl amount was added twice, and the culture was terminated in 36 hours. Table 5 shows the yield of L-glutamic acid accumulated in the fermentation broth relative to the carbon source used.
Claims (1)
有し、かつL−グルタミン酸生産能を有する微生
物を液体培養中に好気的に培養し、培地中に生成
蓄積されたL−グルタミン酸を採取することを特
徴とする発酵法によるL−グルタミン酸の製造
法。 2 液体培地が炭素源として脂肪族アルコール又
は脂肪酸、及び糖質を含有するものである特許請
求の範囲第1項記載の製造法。[Scope of Claims] 1. A microorganism belonging to the genus Brevibacterium, having an acetic acid auxotrophy, and an ability to produce L-glutamic acid is cultivated aerobically in a liquid culture, and the L-glutamic acid produced and accumulated in the medium is - A method for producing L-glutamic acid by a fermentation method, which comprises collecting glutamic acid. 2. The production method according to claim 1, wherein the liquid medium contains an aliphatic alcohol or fatty acid as a carbon source, and a carbohydrate.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17092779A JPS5692794A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
US06/218,071 US4368266A (en) | 1979-12-27 | 1980-12-19 | Method for producing L-glutamic acid by fermentation |
FR8027549A FR2472610A1 (en) | 1979-12-27 | 1980-12-24 | MUTANTS AND METHOD FOR PRODUCING L-GLUTAMIC ACID BY FERMENTATION |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17092779A JPS5692794A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5692794A JPS5692794A (en) | 1981-07-27 |
JPS6236675B2 true JPS6236675B2 (en) | 1987-08-07 |
Family
ID=15913932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17092779A Granted JPS5692794A (en) | 1979-12-27 | 1979-12-27 | Preparation of l-glutamic acid by fermentation method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5692794A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2248906A4 (en) | 2008-01-23 | 2012-07-11 | Ajinomoto Kk | Method of producing l-amino acid |
-
1979
- 1979-12-27 JP JP17092779A patent/JPS5692794A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5692794A (en) | 1981-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5484714A (en) | Method of producing trehalose by microorganisms which can produce tremalose with sucrose or maltose as main carbon source | |
JPS6236676B2 (en) | ||
JP3301140B2 (en) | Method for producing L-glutamic acid by fermentation method | |
JP3016883B2 (en) | Method for producing 5'-xanthylic acid by fermentation method | |
JP3008565B2 (en) | Method for producing L-glutamic acid by fermentation method | |
JPS6115695A (en) | Preparation of l-isoleucine by fermentation method | |
JPS6224073B2 (en) | ||
JPH10248588A (en) | Production of l-serine by fermentation | |
US4368266A (en) | Method for producing L-glutamic acid by fermentation | |
JPS6224074B2 (en) | ||
US5272067A (en) | Process for producing L-glutamic acid | |
JPS6236675B2 (en) | ||
JPS6236677B2 (en) | ||
US3759789A (en) | Process for the microbial production of lysine and isoleucine | |
EP0844308A2 (en) | Method for producing L-glutamic acid by continuous fermentation | |
JP2817228B2 (en) | Method for producing L-glutamic acid | |
JPS61119194A (en) | Production of l-ornithine through fermentation process | |
JPH0358716B2 (en) | ||
JPS61139398A (en) | Production of l-glutamic acid | |
KR880001945B1 (en) | Process for preparing l-glutamic acid by microorganism | |
JPS58141789A (en) | Preparation of l-glutamic acid by fermentation | |
JPS6143038B2 (en) | ||
JPH0313874B2 (en) | ||
JPS6324896A (en) | Production of l-glutamic acid by fermentation | |
JPH0411195B2 (en) |